Know Labs raises $300K in registered direct offering of units at $0.24 per unit

USBC, Inc.

1,250,000 units sold at $0.24/unit, each unit = one share + one warrant exercisable at $0.24 for 5 years.
Gross proceeds ~$300K before fees; net proceeds for KnowU glucose monitor development, clinical studies, and working capital.
Placement agent Boustead Securities receives 7% cash fee and a warrant for 87,500 shares at $0.24.
Warrants include cashless exercise option; offering priced at-the-market under NYSE American rules.
Offered via effective shelf registration S-3 (File 333-276246) and prospectus supplement filed December 13, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.